Sean Patrick Nordt

Sean Patrick Nordt

Auto-generated profile, based on publicly available information

Sean Patrick Nordt

University of Southern California, Department of Emergency Medicine, Los Angeles, California

Research Focus & Metrics

Academic Career Length

31Years (1996-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
25 February 2012 in Journal of Community Health
Verified
Journal Article
Closed access
PDF file
SNSean Patrick Nordt
Sean Patrick Nordt
GVGary M. Vilke
Gary M. Vilke
RCRichard F. Clark
Richard F. Clark
FCF. Lee Cantrell
F. Lee Cantrell
TCTheodore C. Chan
Theodore C. Chan
ECEdward M. Castillo
Edward M. Castillo

13 December 2011 in Clinical Toxicology
Verified
Journal Article
Closed access
PDF file
SNSean Patrick Nordt
Sean Patrick Nordt
RCRichard F. Clark
Richard F. Clark
ALAngie Lee
Angie Lee
KBKacie Berk
Kacie Berk
FCF. Lee Cantrell
F. Lee Cantrell
Objectives. Following widow spider (Latrodectus sp.) envenomation, local pain, erythema, abdominal pain, rigidity, hypertension, and diaphoresis can be seen. While an effective specific antivenom (AV) is available, its use is limited due to concern of possible severe allergic reaction. We performed the current study to determine rate of adverse effects and the efficacy of AV in patients treated for widow spider envenomation. Methods. Observational case series of the California Poison Control System electronic database from January 1999 to December 2009. All cases of widow spider envenomation treated with AV were included. Age, gender, signs, and symptoms, adjunctive therapy, number of vials of AV given, and adverse reaction to AV were recorded. Descriptive statistical methods were used. Results. Ninety-six patients received AV, mean age 26 years (0.12–74 years), 76% male. Following widow spider envenomation generalized pain was reported in 91%, erythema at site in 57%, hypertension (≥ 140/90 mmHg) in 43%, muscle rigidity/cramping in 43%, abdominal pain in 41%, tachycardia (≥ 100 bpm) in 23% and diaphoresis in 21%. No patient required more than one vial of AV. One patient developed urticaria to AV halfway through infusion which was immediately discontinued. Another patient developed generalized flushing following completion of infusion but had no other effects. Two other patients reported myalgia and paresthesia. There were no deaths in any patients receiving AV. There was no shortness of breath or respiratory distress, no hypotension or chest pain following AV administration. All patients reported pain relief with AV and did not require additional AV doses. Conclusions. Our results suggest that Black Widow Spider Antivenin® (Merck) administration is relatively safe with mild to moderate adverse effects seen in only a small percentage of patients. There were no deaths, or severe allergic reactions identified. The retrospective use of poison control system data is a limitation of our study. Further prospective studies are needed to validate our findings and elucidate the full safety profile on this antivenom.

1 January 2011 in Western Journal of Emergency Medicine
Verified
Journal Article
Open access
PDF file
SNSean Patrick Nordt
Sean Patrick Nordt
RCRichard F. Clark
Richard F. Clark
ECEdward M. Castillo
Edward M. Castillo
DGDavid A. Guss
David A. Guss
Introduction: The treatment of acute coronary syndrome (ACS) includes the administration of aspirin. Current guidelines recommend chewing aspirin tablets to increase absorption. While this is intuitive, there are scant data supporting this recommendation. The purpose of this study is to assess which of 3 different aspirin formulations is most rapidly absorbed after ingestion.Methods: A prospective, open-label, 3-way crossover volunteer study at a tertiary university medical center with human subjects 18 years or older. Fasted subjects were randomly assigned to receive aspirin 1,950 mg as (1) solid aspirin tablets swallowed whole, (2) solid aspirin tablet chewed then swallowed, or (3) a chewable aspirin formulation chewed and swallowed. Serum salicylate measurements were obtained over a period of 180 minutes. Pharmacokinetic parameters were determined.Results: Thirteen males and 1 female completed all 3 arms of study. Peak serum salicylate concentrations were seen at 180 minutes in all groups. Mean peaks were 10.4, 11.3, and 12.2 mg/dL in groups 1, 2, and 3, respectively. Mean area under the time concentration was 1,153, 1,401, and 1,743 mg-min/dL in groups 1, 2, and 3, respectively. No measurable salicylate concentrations were seen in 6 subjects in group 1 at 60 minutes as compared to 1 subject in group 2. All subjects in group 3 had measurable levels at 45 minutes. There were no adverse effects in any of the subjects during the study period.Conclusion: Our data demonstrate that the chewable aspirin formulation achieved the most rapid rate of absorption. In addition, the chewable formulation absorption was more complete than the other formulations at 180 minutes. These data suggest that in the treatment of ACS, a chewable aspirin formulation may be preferable to solid tablet aspirin, either chewed or swallowed. [West J Emerg Med. 2011;12(4):381–385.]

1 January 1996 in Journal of Toxicology: Clinical Toxicology
Verified
Journal Article
Closed access
PDF file
SNSean P. Nordt
Sean P. Nordt
SWSaralyn R. Williams
Saralyn R. Williams
STSteven Turchen
Steven Turchen
AMAnthony Manoguerra
Anthony Manoguerra
DSDavid Smith
David Smith
RCRichard F. Clark
Richard F. Clark
Case Report: Hypermagnesemia is a rare condition that commonly follows excessive therapeutic administration of magnesium sulfate to treat eclampsia of pregnancy. Signs and symptoms of this condition include extreme muscle weakness, loss of deep tendon reflexes, mental status depression, and cardiac dysrhythmias. Clinically significant hypermagnesemia following oral or rectal administration of magnesium containing products in patients with normal renal function is rare. We report a case of hypermagnesemia following massive Epsom salt ingestion that resulted in extreme musculoskeletal weakness and altered mentation.

13 June 2015 in The American Journal of Emergency Medicine
Verified
Journal Article
Closed access
PDF file
SNSean Patrick Nordt
Sean Patrick Nordt
DPDavid Pomeranz
David Pomeranz

23 January 2023 in The American Journal of Emergency Medicine
Verified
Journal Article
Closed access
SNSean Patrick Nordt
Sean Patrick Nordt
JRJohn M. Ryan
John M. Ryan
DKDaniel Kelly
Daniel Kelly
AKAbdubadie Kutubi
Abdubadie Kutubi
RSRenad Saleh
Renad Saleh
ETEoin J. Tiernan
Eoin J. Tiernan